Trial intelligence / Profile preview

TCRα/β Depletion and CD45RA-Depleted DLI for SCID

NCT03597594Phase 2Active, not recruiting

Sponsor
St. Jude Children's Research Hospital
Start
Sep 2021
Primary completion
Jul 2027
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

A Phase 2 trial of donor lymphocyte infusion in severe combined immunodeficiency (SCID), sponsored by St. Jude Children's Research Hospital. Started Sep 2021; status: active, not recruiting.

02

Drugs

donor lymphocyte infusion
03

Conditions

severe combined immunodeficiency (SCID)

Beyond the preview

Go deeper on NCT03597594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03597594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call